Study to Evaluate the Efficacy and Safety of Nizubaglustat (AZ-3102) in Patients With Gaucher Disease Type 3 (GD3)
Clinical trial NCT07715084 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07715084
- Sponsor
- Azafaros B.V.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-09-28
- Primary completion
- 2028-01-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.